← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

EHAB logoEnhabit, Inc.(EHAB)Earnings, Financials & Key Ratios

EHAB•NYSE
$13.77
$705M mkt cap·Price updated May 6, 2026
SectorHealthcareIndustryHealthcare FacilitiesSub-IndustryHome-based care services
AboutEnhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company also offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of March 31, 2022, it operated in 252 home health agencies and 99 hospice agencies across 34 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is headquartered in Dallas, Texas. As of July 1, 2022, Enhabit, Inc. operates as a standalone company.Show more
  • Revenue$1.06B+2.4%
  • EBITDA$86M+203.2%
  • Net Income-$5M+97.1%
  • EPS (Diluted)-0.09+97.1%
  • Gross Margin46.92%-3.7%
  • EBITDA Margin8.14%+200.8%
  • Operating Margin6.02%+154.1%
  • Net Margin-0.43%+97.1%
  • ROE-0.82%+96.7%
  • ROIC4.52%+162.3%
  • Debt/Equity0.89-13.8%
  • Interest Coverage1.88+169.9%
Technical→

EHAB Key Insights

Enhabit, Inc. (EHAB) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Momentum leader: RS Rating 85 (top 15%)
  • ✓Trading near 52-week high
  • ✓Trading at only 1.2x book value

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

EHAB Price & Volume

Enhabit, Inc. (EHAB) stock price & volume — 10-year historical chart

Loading chart...

EHAB Growth Metrics

Enhabit, Inc. (EHAB) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-0.34%
3 Years-0.35%
TTM2.44%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM97.06%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM97.12%

Return on Capital

10 Years1.37%
5 Years0.27%
3 Years-2.4%
Last Year5.96%

EHAB Recent Earnings

Enhabit, Inc. (EHAB) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 6/12 qtrs (50%)●Beat Revenue 2/12 qtrs (17%)
Q2 2026Latest
Mar 4, 2026
EPS
$0.14
Est $0.14
+0.0%
Revenue
$270M
Est $271M
-0.1%
Q4 2025
Nov 5, 2025
EPS
$0.17
Est $0.12
+41.7%
Revenue
$264M
Est $271M
-2.6%
Q3 2025
Aug 6, 2025
EPS
$0.13
Est $0.10
+30.0%
Revenue
$266M
Est $263M
+1.0%
Q2 2025
May 7, 2025
EPS
$0.10
Est $0.07
+42.9%
Revenue
$260M
Est $266M
-2.3%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMar 4, 2026
$0.14vs $0.14+0.0%
$270Mvs $271M-0.1%
Q4 2025Nov 5, 2025
$0.17vs $0.12+41.7%
$264Mvs $271M-2.6%
Q3 2025Aug 6, 2025
$0.13vs $0.10+30.0%
$266Mvs $263M+1.0%
Q2 2025May 7, 2025
$0.10vs $0.07+42.9%
$260Mvs $266M-2.3%
Based on last 12 quarters of dataView full earnings history →

EHAB Peer Comparison

Enhabit, Inc. (EHAB) competitors in Home-based care services — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
ADUS logoADUSAddus HomeCare CorporationDirect Competitor1.8B96.6418.5523.21%6.89%9.34%0.19
ENSG logoENSGThe Ensign Group, Inc.Product Competitor10.28B175.9330.1318.72%6.89%16.61%1.86
SGRY logoSGRYSurgery Partners, Inc.Product Competitor1.89B14.59-23.926.24%-2.28%-2.39%1.14
ACHC logoACHCAcadia Healthcare Company, Inc.Product Competitor2.33B25.30-2.085.04%-32.84%-40.92%1.24
SEM logoSEMSelect Medical Holdings CorporationProduct Competitor2.04B16.4313.925.12%2.42%6.57%1.82
PNTG logoPNTGThe Pennant Group, Inc.Product Competitor1.13B32.5338.7336.31%2.96%8.42%1.21
UNH logoUNHUnitedHealth Group IncorporatedSupply Chain333.37B367.2827.7611.81%2.68%11.54%0.77
HUM logoHUMHumana Inc.Supply Chain29.57B246.3325.0310.06%0.82%6.17%0.73

Compare EHAB vs Peers

Enhabit, Inc. (EHAB) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ADUS

Most directly comparable listed peer for EHAB.

Scale Benchmark

vs UNH

Larger-name benchmark to compare EHAB against a more recognizable public peer.

Peer Set

Compare Top 5

vs ADUS, ENSG, SGRY, ACHC

EHAB Income Statement

Enhabit, Inc. (EHAB) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Sales/Revenue1.08B1.11B1.07B1.05B1.03B1.06B
Revenue Growth %-2.63%-3.21%-2.32%-1.1%2.44%
Cost of Goods Sold537.5M513.9M525.6M535.6M530.8M562.7M
COGS % of Revenue49.85%46.44%49.07%51.19%51.29%53.08%
Gross Profit
540.7M▲ 0%
592.7M▲ 9.6%
545.5M▼ 8.0%
510.7M▼ 6.4%
504M▼ 1.3%
497.3M▼ 1.3%
Gross Margin %50.15%53.56%50.93%48.81%48.71%46.92%
Gross Profit Growth %-9.62%-7.96%-6.38%-1.31%-1.33%
Operating Expenses438M449.8M556.9M558.3M619.1M433.5M
OpEx % of Revenue40.62%40.65%51.99%53.36%59.83%40.9%
Selling, General & Admin398M412.9M414.9M441.6M425.9M433.5M
SG&A % of Revenue36.91%37.31%38.74%42.21%41.16%40.9%
Research & Development000000
R&D % of Revenue------
Other Operating Expenses40M36.9M142M116.7M193.2M0
Operating Income
102.7M▲ 0%
142.9M▲ 39.1%
-11.4M▼ 108.0%
-47.6M▼ 317.5%
-115.1M▼ 141.8%
63.8M▲ 155.4%
Operating Margin %9.53%12.91%-1.06%-4.55%-11.12%6.02%
Operating Income Growth %-39.14%-107.98%-317.54%-141.81%155.43%
EBITDA142.7M179.8M21.6M-16.7M-83.6M86.3M
EBITDA Margin %13.23%16.25%2.02%-1.6%-8.08%8.14%
EBITDA Growth %-26%-87.99%-177.31%-400.6%203.23%
D&A (Non-Cash Add-back)40M36.9M33M30.9M31.5M22.5M
EBIT105.4M148.3M-10.5M-47.4M-115.1M63.8M
Net Interest Income-5.2M-300K-15M-43M-42.9M-33.8M
Interest Income00000200K
Interest Expense5.2M300K15M43M42.9M34M
Other Income/Expense-2.5M5.1M-14.1M-42.8M-42.9M-62.4M
Pretax Income
100.2M▲ 0%
148M▲ 47.7%
-25.5M▼ 117.2%
-90.4M▼ 254.5%
-158M▼ 74.8%
1.4M▲ 100.9%
Pretax Margin %9.29%13.37%-2.38%-8.64%-15.27%0.13%
Income Tax24.4M35.1M12.8M-11.4M-4M4M
Effective Tax Rate %24.35%23.72%-50.2%12.61%2.53%285.71%
Net Income
75M▲ 0%
111.1M▲ 48.1%
-40.4M▼ 136.4%
-80.5M▼ 99.3%
-156.2M▼ 94.0%
-4.6M▲ 97.1%
Net Margin %6.96%10.04%-3.77%-7.69%-15.09%-0.43%
Net Income Growth %-48.13%-136.36%-99.26%-94.04%97.06%
Net Income (Continuing)75.8M112.9M-38.3M-79M-154M-2.6M
Discontinued Operations000000
Minority Interest6.7M13.3M33.6M32M30.4M30.1M
EPS (Diluted)
19.23▲ 0%
28.49▲ 48.2%
1.25▼ 95.6%
-1.61▼ 228.8%
-3.11▼ 93.2%
-0.09▲ 97.1%
EPS Growth %-48.15%-95.61%-228.8%-93.17%97.09%
EPS (Basic)19.2328.491.25-1.61-3.11-0.09
Diluted Shares Outstanding3.9M3.9M50.1M49.9M50.2M50.8M
Basic Shares Outstanding3.9M3.9M50.1M50.05M50.2M50.8M
Dividend Payout Ratio192.67%138.7%----

EHAB Balance Sheet

Enhabit, Inc. (EHAB) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Total Current Assets182.6M178.8M211.8M210.1M192.7M205.6M
Cash & Short-Term Investments38.5M5.4M22.9M27.4M28.4M43.6M
Cash Only38.5M5.4M22.9M27.4M28.4M43.6M
Short-Term Investments000000
Accounts Receivable136.5M164.5M161M164.7M149.2M144M
Days Sales Outstanding46.2154.2654.8657.4652.6349.58
Inventory000000
Days Inventory Outstanding------
Other Current Assets1.5M2.6M27.9M18M15.1M18M
Total Non-Current Assets1.43B1.54B1.31B1.22B1.03B961.5M
Property, Plant & Equipment65.1M68.8M62.4M76.5M70.5M65.3M
Fixed Asset Turnover16.56x16.08x17.17x13.68x14.68x16.23x
Goodwill1.09B1.19B1.14B1.06B900M855.3M
Intangible Assets269.4M259.1M102.6M80M58.1M38.5M
Long-Term Investments00000500K
Other Non-Current Assets11M24.3M5.2M5.3M4.7M1.9M
Total Assets
1.62B▲ 0%
1.72B▲ 6.4%
1.53B▼ 11.2%
1.43B▼ 6.1%
1.23B▼ 14.5%
1.17B▼ 4.8%
Asset Turnover0.67x0.64x0.70x0.73x0.84x0.91x
Asset Growth %-6.38%-11.23%-6.1%-14.48%-4.8%
Total Current Liabilities126.9M136.5M132.9M137.7M126.2M126.3M
Accounts Payable3.4M3.5M3.8M7.6M6.7M9.2M
Days Payables Outstanding2.312.492.645.184.615.97
Short-Term Debt6.5M5M23.1M22.5M22.8M22.3M
Deferred Revenue (Current)000000
Other Current Liabilities34.1M24.8M40.7M40.7M36.4M82.2M
Current Ratio1.44x1.31x1.59x1.53x1.53x1.63x
Quick Ratio1.44x1.31x1.59x1.53x1.53x1.63x
Cash Conversion Cycle------
Total Non-Current Liabilities100.1M100.2M618.6M594.2M545.9M503.6M
Long-Term Debt3.2M3.5M560M530.1M492.6M423.7M
Capital Lease Obligations27.3M33.5M28.1M45.7M41.8M41.4M
Deferred Tax Liabilities54.7M63.2M28.6M17.1M11.5M38.4M
Other Non-Current Liabilities14.9M01.9M1.3M0100K
Total Liabilities227M236.7M751.5M731.9M672.1M603M
Total Debt50.5M56.9M625.2M610.1M569.5M500M
Net Debt12M51.5M602.3M582.7M541.1M456.4M
Debt / Equity0.04x0.04x0.81x0.87x1.03x0.89x
Debt / EBITDA0.35x0.32x28.94x--5.79x
Net Debt / EBITDA0.08x0.29x27.88x--5.29x
Interest Coverage20.27x494.33x-0.70x-1.10x-2.68x1.88x
Total Equity
1.39B▲ 0%
1.48B▲ 6.7%
775.3M▼ 47.7%
701.7M▼ 9.5%
553.9M▼ 21.1%
564.1M▲ 1.8%
Equity Growth %-6.73%-47.73%-9.49%-21.06%1.84%
Book Value per Share356.36380.3315.4814.0611.0311.10
Total Shareholders' Equity1.38B1.47B741.7M669.7M523.5M534M
Common Stock100K500K500K500K500K500K
Retained Earnings264.3M375.4M335M254.5M98.3M93.7M
Treasury Stock000-600K-1.7M-3.8M
Accumulated OCI00-700K-500K-200K0
Minority Interest6.7M13.3M33.6M32M30.4M30.1M

EHAB Cash Flow Statement

Enhabit, Inc. (EHAB) cash flow — operating, investing & free cash flow history

Line itemDec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Cash from Operations24.9M123.3M80.1M48.4M51.2M70.7M
Operating CF Margin %2.31%11.14%7.48%4.63%4.95%6.67%
Operating CF Growth %-395.18%-35.04%-39.58%5.79%38.09%
Net Income75M112.9M-38.3M-80.5M-154M-2.6M
Depreciation & Amortization40M36.9M33M30.9M31.5M22.5M
Stock-Based Compensation03.6M9.2M8.9M11.7M16.6M
Deferred Taxes18.5M8.6M-4.3M-11.6M-5.7M0
Other Non-Cash Items3.5M-5.9M109.7M89M162.6M30.4M
Working Capital Changes-112.1M-32.8M-29.2M11.7M5.1M3.8M
Change in Receivables-32.9M-24.8M21.6M-14.6M15.5M5.2M
Change in Inventory000000
Change in Payables-500K-700K200K3.8M-1M2.6M
Cash from Investing-3M-119.2M-42.3M-5.3M-2.4M16.7M
Capital Expenditures-3.6M-4.3M-7.1M-3.5M-3.8M-4.9M
CapEx % of Revenue0.33%0.39%0.66%0.33%0.37%0.46%
Acquisitions-1.1M-117.5M-36.3M-2.8M00
Investments------
Other Investing1.7M2.6M1.1M1M1.4M19.8M
Cash from Financing-16.7M-36.1M-18.6M-40.5M-48.3M-72.2M
Debt Issued (Net)5.1M-7.2M575M-33.4M-43.6M-67.7M
Equity Issued (Net)124M00000
Dividends Paid-144.5M-154.1M-654.9M000
Share Repurchases000000
Other Financing-1.3M125.2M61.3M-7.1M-4.7M-4.5M
Net Change in Cash
40M▲ 0%
-32M▼ 180.0%
19.2M▲ 160.0%
2.6M▼ 86.5%
500K▼ 80.8%
15.2M▲ 2940.0%
Free Cash Flow
21.7M▲ 0%
119M▲ 448.4%
73M▼ 38.7%
44.9M▼ 38.5%
47.4M▲ 5.6%
65.8M▲ 38.8%
FCF Margin %2.01%10.75%6.82%4.29%4.58%6.21%
FCF Growth %-448.39%-38.66%-38.49%5.57%38.82%
FCF per Share5.5630.511.460.900.941.30
FCF Conversion (FCF/Net Income)0.33x1.11x-1.98x-0.60x-0.33x-15.37x
Interest Paid0200K13.1M000
Taxes Paid028.4M11.9M000

EHAB Key Ratios

Enhabit, Inc. (EHAB) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric202020212022202320242025
Return on Equity (ROE)5.4%7.73%-3.58%-10.9%-24.88%-0.82%
Return on Invested Capital (ROIC)5.49%7.3%-0.59%-2.68%-7.26%4.52%
Gross Margin50.15%53.56%50.93%48.81%48.71%46.92%
Net Margin6.96%10.04%-3.77%-7.69%-15.09%-0.43%
Debt / Equity0.04x0.04x0.81x0.87x1.03x0.89x
Interest Coverage20.27x494.33x-0.70x-1.10x-2.68x1.88x
FCF Conversion0.33x1.11x-1.98x-0.60x-0.33x-15.37x
Revenue Growth-2.63%-3.21%-2.32%-1.1%2.44%

EHAB SEC Filings & Documents

Enhabit, Inc. (EHAB) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 5, 2026·SEC

Material company update

Apr 16, 2026·SEC

Material company update

Mar 5, 2026·SEC

10-K Annual Reports

2
FY 2026

Mar 5, 2026·SEC

FY 2025

Mar 6, 2025·SEC

10-Q Quarterly Reports

5
FY 2025

Nov 5, 2025·SEC

FY 2025

Aug 7, 2025·SEC

FY 2025

May 8, 2025·SEC

EHAB Frequently Asked Questions

Enhabit, Inc. (EHAB) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Enhabit, Inc. (EHAB) reported $1.06B in revenue for fiscal year 2025. This represents a 2% decrease from $1.08B in 2020.

Enhabit, Inc. (EHAB) grew revenue by 2.4% over the past year. Growth has been modest.

Enhabit, Inc. (EHAB) reported a net loss of $4.6M for fiscal year 2025.

Dividend & Returns

Enhabit, Inc. (EHAB) has a return on equity (ROE) of -0.8%. Negative ROE indicates the company is unprofitable.

Enhabit, Inc. (EHAB) generated $65.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More EHAB

Enhabit, Inc. (EHAB) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.